RE46,363 All claims, counterclaims, affirmative defenses, and demands are dismissed without prejudice and without costs, disbursements, or attorneys’ fees to any party. The parties each ...

Sun Pharma announced a 15 per cent year-on-year (YoY) increase, reaching ₹2,903 crore for the quarter ending December 2024. The company also recorded an exceptional item of ₹316 crore during ...

Sun Pharmaceutical Industries Ltd. closed 13.04% below its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Opens in a new tab or window SAN FRANCISCO -- The addition of radionuclide therapy with 177 Lu-PSMA-617 (Pluvicto) to enzalutamide ... from Novartis and Clarity Pharma; consulting fees for ...

Caught amidst tariff concerns shares of India's prominent drugmakers--Dr Reddy's Laboratories, Sun Pharma, Lupin, Cipla, Zydus Life and Aurobindo Pharma--slipped 1-4 percent. These companies have ...

Dilip Shanghvi, Founder and Managing Director of Sun Pharmaceutical Industries, has indicated potential plans to segment the ...

BENGALURU (Reuters) -India's drug regulator has found more than 50 drugs, including some batches of widely used antacids and paracetamol, to be substandard or fake, according to government documents.

Considering today's low, the Nifty pharma index has fallen over 7 per cent in the last three days. On a monthly scale, the index has declined nearly 12 per cent against a 3 per cent fall in the ...

This study was sponsored by Pfizer, Inc. Astellas Pharma Inc. provided enzalutamide. Agarwal had disclosed relationships with Pfizer, Janssen, Bayer, Amgen, and others. Kelly had disclosed ...

A US district court has granted an injunction sought by Incyte on the launch of Sun Pharma's recently approved Leqselvi for alopecia areata. In a brief filing with the National Stock Exchange (NSE ...